和谐代灵
Lv61
3190 积分
2023-02-18 加入
-
Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD
27天前
已完结
-
Hepatotoxicity and cutaneous reactions after antithyroid drug administration
28天前
已完结
-
Hepatotoxicity and cutaneous reactions after antithyroid drug administration
28天前
已关闭
-
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study
2个月前
已完结
-
Targeting human Glucokinase for the treatment of type 2 diabetes: an overview of allosteric Glucokinase activators
2个月前
已完结
-
870-P: Long-Term Efficacy and Safety of Crisugabalin Besilate in Chinese patients with Diabetic Peripheral Neuropathic Pain
3个月前
已完结
-
868-P: Efficacy and Safety of Crisugabalin with Acetyl-Levo-Carnitine in Chinese Patients with Diabetic Peripheral Neuropathic Pain—A Multicentre, Randomized, Open-Label, Positive-Controlled, Parallel-Group, Phase 2 Trial
3个月前
已关闭
-
EP145 Efficacy and safety of crisugabalin for the treatment of perioperative analgesia in patients undergoing orthopedic surgery: a multi-centre, randomized, double-blind, placebo-controlled, phase 2 trial
3个月前
已完结
-
Effect of polyethylene Glycol Loxenatide (long-acting GLP-1RA) on lipid, glucose levels and weight in type 2 diabetes mellitus patients with obesity
3个月前
已完结
-
Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years
3个月前
已完结